Curative Biotechnology(CUBT)
$0.85+0.04 (+5.59%)
CUBT
Curative Biotechnology financials statements
$0.85
At close:+0.04 (+5.59%)
Curative Biotechnology (CUBT) Income Statement
20 Followers
Curative Biotechnology Income Statement
Last quarter (Q2 2026), Curative Biotechnology's total revenue was $0.00. In Q2, Curative Biotechnology's net income was $-608.91K. See Curative Biotechnology’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ -87.84K | $ -92.21K | $ -97.52K | $ -7.96K | $ -6.74K | |
| $ 1.41M | $ 2.35M | $ 1.83M | $ 4.44M | $ 5.00M | |
| Depreciation and Amortization | $ 87.84K | $ 92.21K | $ 97.52K | $ 99.80K | $ 6.74K |
| $ -1.41M | $ -2.35M | $ -2.50M | $ -4.36M | $ -5.16M | |
| $ -1.50M | $ -2.44M | $ -1.93M | $ -4.47M | $ -5.01M | |
| $ -761.01K | $ -1.12M | $ -2.02M | $ -913.57K | $ -326.00K | |
| $ -2.26M | $ -3.56M | $ -3.96M | $ -5.38M | $ -5.34M | |
| $ -2.26M | $ -3.56M | $ -3.96M | $ -5.38M | $ -5.34M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.00 | $ -0.60 | $ -1.32 | $ -1.47 | $ -5.64 |
| Diluted EPS | $ -0.00 | $ -0.60 | $ -1.32 | $ -1.44 | $ -5.64 |
| Weighted Average Shares Outstanding | 1.02B | 6.05M | 4.41M | 3.75M | 2.15M |
| Weighted Average Shares Outstanding (Diluted) | 1.02B | 6.05M | 4.41M | 3.81M | 2.15M |
Currency in USD

